Miranda C - Search Results

1

Rearrangements of NTRK1 gene in papillary thyroid carcinoma.

Greco A, Miranda C, Pierotti MA. Greco A, et al. Among authors: miranda c. Mol Cell Endocrinol. 2010 May 28;321(1):44-9. doi: 10.1016/j.mce.2009.10.009. Epub 2009 Oct 31. Mol Cell Endocrinol. 2010. PMID: 19883730 Review.

2

Gain of function mutations of RTK conserved residues display differential effects on NTRK1 kinase activity.

Miranda C, Zanotti G, Pagliardini S, Ponzetto C, Pierotti MA, Greco A. Miranda C, et al. Oncogene. 2002 Nov 28;21(54):8334-9. doi: 10.1038/sj.onc.1206052. Oncogene. 2002. PMID: 12447696

3

The signaling adapters fibroblast growth factor receptor substrate 2 and 3 are activated by the thyroid TRK oncoproteins.

Ranzi V, Meakin SO, Miranda C, Mondellini P, Pierotti MA, Greco A. Ranzi V, et al. Among authors: miranda c. Endocrinology. 2003 Mar;144(3):922-8. doi: 10.1210/en.2002-221002. Endocrinology. 2003. PMID: 12586769

4

RET and NTRK1 proto-oncogenes in human diseases.

Alberti L, Carniti C, Miranda C, Roccato E, Pierotti MA. Alberti L, et al. Among authors: miranda c. J Cell Physiol. 2003 May;195(2):168-86. doi: 10.1002/jcp.10252. J Cell Physiol. 2003. PMID: 12652644 Review.

5

Analysis of SHP-1-mediated down-regulation of the TRK-T3 oncoprotein identifies Trk-fused gene (TFG) as a novel SHP-1-interacting protein.

Roccato E, Miranda C, Raho G, Pagliardini S, Pierotti MA, Greco A. Roccato E, et al. Among authors: miranda c. J Biol Chem. 2005 Feb 4;280(5):3382-9. doi: 10.1074/jbc.M407522200. Epub 2004 Nov 22. J Biol Chem. 2005. PMID: 15557341 Free article.

6

The TFG protein, involved in oncogenic rearrangements, interacts with TANK and NEMO, two proteins involved in the NF-kappaB pathway.

Miranda C, Roccato E, Raho G, Pagliardini S, Pierotti MA, Greco A. Miranda C, et al. J Cell Physiol. 2006 Jul;208(1):154-60. doi: 10.1002/jcp.20644. J Cell Physiol. 2006. PMID: 16547966

7

Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma.

Ferrario C, Lavagni P, Gariboldi M, Miranda C, Losa M, Cleris L, Formelli F, Pilotti S, Pierotti MA, Greco A. Ferrario C, et al. Among authors: miranda c. Lab Invest. 2008 May;88(5):474-81. doi: 10.1038/labinvest.2008.17. Epub 2008 Mar 10. Lab Invest. 2008. PMID: 18332874 Free article.

8

Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas.

Degl'Innocenti D, Alberti C, Castellano G, Greco A, Miranda C, Pierotti MA, Seregni E, Borrello MG, Canevari S, Tomassetti A. Degl'Innocenti D, et al. Among authors: miranda c. PLoS One. 2010 Sep 22;5(9):e12701. doi: 10.1371/journal.pone.0012701. PLoS One. 2010. PMID: 20877637 Free PMC article.

9

S100A11 overexpression contributes to the malignant phenotype of papillary thyroid carcinoma.

Anania MC, Miranda C, Vizioli MG, Mazzoni M, Cleris L, Pagliardini S, Manenti G, Borrello MG, Pierotti MA, Greco A. Anania MC, et al. Among authors: miranda c. J Clin Endocrinol Metab. 2013 Oct;98(10):E1591-600. doi: 10.1210/jc.2013-1652. Epub 2013 Aug 8. J Clin Endocrinol Metab. 2013. PMID: 23928665

10

Functional characterization of NTRK1 mutations identified in melanoma.

Miranda C, Mazzoni M, Sensi M, Pierotti MA, Greco A. Miranda C, et al. Genes Chromosomes Cancer. 2014 Oct;53(10):875-80. doi: 10.1002/gcc.22200. Epub 2014 Jun 26. Genes Chromosomes Cancer. 2014. PMID: 24965840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,340 results

Search Page

Filters